Solid Biosciences price target raised to $26 from $16 at Cantor Fitzgerald
very_bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
very_bullish
What happened, with direct paths to the underlying reporting
Cantor Fitzgerald raises SLDB target to $26 from $16; current price $9.72.
Target: $26
Posted price: $9.72
Analyst firm: Cantor Fitzgerald
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.